JP2022524435A5 - - Google Patents
Info
- Publication number
- JP2022524435A5 JP2022524435A5 JP2021554697A JP2021554697A JP2022524435A5 JP 2022524435 A5 JP2022524435 A5 JP 2022524435A5 JP 2021554697 A JP2021554697 A JP 2021554697A JP 2021554697 A JP2021554697 A JP 2021554697A JP 2022524435 A5 JP2022524435 A5 JP 2022524435A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024116841A JP2024133347A (ja) | 2019-03-11 | 2024-07-22 | Ｒｎａ誘導型エンドヌクレアーゼを使用したｄｎａ構築物の組み込みプロセスの向上 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962816836P | 2019-03-11 | 2019-03-11 | |
| US62/816,836 | 2019-03-11 | ||
| US201962901735P | 2019-09-17 | 2019-09-17 | |
| US62/901,735 | 2019-09-17 | ||
| PCT/US2020/022056 WO2020185867A1 (en) | 2019-03-11 | 2020-03-11 | Improved process for integration of dna constructs using rna-guided endonucleases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024116841A Division JP2024133347A (ja) | 2019-03-11 | 2024-07-22 | Ｒｎａ誘導型エンドヌクレアーゼを使用したｄｎａ構築物の組み込みプロセスの向上 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022524435A JP2022524435A (ja) | 2022-05-02 |
| JP2022524435A5 true JP2022524435A5 (https=) | 2023-03-15 |
| JPWO2020185867A5 JPWO2020185867A5 (https=) | 2023-03-15 |
Family
ID=70190148
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021554697A Pending JP2022524435A (ja) | 2019-03-11 | 2020-03-11 | Ｒｎａ誘導型エンドヌクレアーゼを使用したｄｎａ構築物の組み込みプロセスの向上 |
| JP2024116841A Pending JP2024133347A (ja) | 2019-03-11 | 2024-07-22 | Ｒｎａ誘導型エンドヌクレアーゼを使用したｄｎａ構築物の組み込みプロセスの向上 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024116841A Pending JP2024133347A (ja) | 2019-03-11 | 2024-07-22 | Ｒｎａ誘導型エンドヌクレアーゼを使用したｄｎａ構築物の組み込みプロセスの向上 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220145333A1 (https=) |
| EP (1) | EP3938510A1 (https=) |
| JP (2) | JP2022524435A (https=) |
| KR (1) | KR20210149734A (https=) |
| CN (1) | CN113825834A (https=) |
| AU (1) | AU2020239050A1 (https=) |
| CA (1) | CA3133226A1 (https=) |
| IL (1) | IL286244A (https=) |
| MX (1) | MX2021010938A (https=) |
| SG (1) | SG11202109972QA (https=) |
| WO (1) | WO2020185867A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4139345A1 (en) | 2020-04-24 | 2023-03-01 | Sorrento Therapeutics, Inc. | Memory dimeric antigen receptors |
| WO2022015956A1 (en) | 2020-07-15 | 2022-01-20 | Sorrento Therapeutics, Inc. | Improved process for dna integration using rna-guided endonucleases |
| WO2022061115A1 (en) * | 2020-09-18 | 2022-03-24 | Vor Biopharma Inc. | Compositions and methods for cd7 modification |
| BR112023018948A2 (pt) * | 2021-03-19 | 2023-10-17 | Metagenomi Inc | Edição multiplex com enzimas cas |
| JP2024513087A (ja) * | 2021-04-07 | 2024-03-21 | アストラゼネカ・アクチエボラーグ | 部位特異的改変のための組成物及び方法 |
| EP4370676A2 (en) * | 2021-06-18 | 2024-05-22 | Artisan Development Labs, Inc. | Compositions and methods for targeting, editing or modifying human genes |
| WO2023097236A1 (en) * | 2021-11-24 | 2023-06-01 | The Rockefeller University | Compositions and methods for generating immunoglobulin knock-in mice |
| CN115851591A (zh) * | 2022-11-30 | 2023-03-28 | 山东博群生物技术有限公司 | 细胞因子刺激剂及诱导淋巴细胞产生细胞因子的方法 |
| WO2026020171A2 (en) | 2024-07-19 | 2026-01-22 | Aera Therapeutics, Inc. | Chimeric antigen receptor constructs |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5034506A (en) | 1985-03-15 | 1991-07-23 | Anti-Gene Development Group | Uncharged morpholino-based polymers having achiral intersubunit linkages |
| US5489677A (en) | 1990-07-27 | 1996-02-06 | Isis Pharmaceuticals, Inc. | Oligonucleoside linkages containing adjacent oxygen and nitrogen atoms |
| US5602240A (en) | 1990-07-27 | 1997-02-11 | Ciba Geigy Ag. | Backbone modified oligonucleotide analogs |
| US6555674B2 (en) | 2000-08-09 | 2003-04-29 | Nsgene A/S | JeT promoter |
| EP2281050B1 (en) * | 2008-04-14 | 2014-04-02 | Sangamo BioSciences, Inc. | Linear donor constructs for targeted integration |
| EP3241902B1 (en) | 2012-05-25 | 2018-02-28 | The Regents of The University of California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| AU2014361834B2 (en) | 2013-12-12 | 2020-10-22 | Massachusetts Institute Of Technology | CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymes |
| WO2016057951A2 (en) * | 2014-10-09 | 2016-04-14 | Life Technologies Corporation | Crispr oligonucleotides and gene editing |
| AU2016261358B2 (en) * | 2015-05-11 | 2021-09-16 | Editas Medicine, Inc. | Optimized CRISPR/Cas9 systems and methods for gene editing in stem cells |
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| AU2016338785B2 (en) * | 2015-10-12 | 2022-07-14 | E. I. Du Pont De Nemours And Company | Protected DNA templates for gene modification and increased homologous recombination in cells and methods of use |
| CA3038960A1 (en) | 2016-09-30 | 2018-04-05 | The Regents Of The University Of California | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
| WO2018175636A2 (en) * | 2017-03-22 | 2018-09-27 | Novartis Ag | Compositions and methods for immunooncology |
| CA3067382A1 (en) * | 2017-06-15 | 2018-12-20 | The Regents Of The University Of California | Targeted non-viral dna insertions |
| CA3071683A1 (en) * | 2017-08-08 | 2019-02-14 | Sangamo Therapeutics, Inc. | Chimeric antigen receptor mediated cell targeting |
| SG11202008568WA (en) | 2018-03-09 | 2020-10-29 | Sorrento Therapeutics Inc | Dimeric antigen receptors (dar) |
-
2020
- 2020-03-11 US US17/438,039 patent/US20220145333A1/en not_active Abandoned
- 2020-03-11 SG SG11202109972Q patent/SG11202109972QA/en unknown
- 2020-03-11 WO PCT/US2020/022056 patent/WO2020185867A1/en not_active Ceased
- 2020-03-11 AU AU2020239050A patent/AU2020239050A1/en not_active Abandoned
- 2020-03-11 KR KR1020217032629A patent/KR20210149734A/ko not_active Withdrawn
- 2020-03-11 CA CA3133226A patent/CA3133226A1/en active Pending
- 2020-03-11 JP JP2021554697A patent/JP2022524435A/ja active Pending
- 2020-03-11 MX MX2021010938A patent/MX2021010938A/es unknown
- 2020-03-11 CN CN202080035087.XA patent/CN113825834A/zh active Pending
- 2020-03-11 EP EP20717424.4A patent/EP3938510A1/en not_active Withdrawn
-
2021
- 2021-09-09 IL IL286244A patent/IL286244A/en unknown
-
2024
- 2024-07-22 JP JP2024116841A patent/JP2024133347A/ja active Pending